Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Tumor Immunology and Immunotherapy Program, State University of New York (SUNY) at Buffalo, Buffalo, New York.
Cancer Discov. 2021 May;11(5):1067-1081. doi: 10.1158/2159-8290.CD-20-1211. Epub 2021 Jan 27.
Metabolic reprogramming enables cancer cell growth, proliferation, and survival. This reprogramming is driven by the combined actions of oncogenic alterations in cancer cells and host cell factors acting on cancer cells in the tumor microenvironment. Cancer cell-intrinsic mechanisms activate signal transduction components that either directly enhance metabolic enzyme activity or upregulate transcription factors that in turn increase expression of metabolic regulators. Extrinsic signaling mechanisms involve host-derived factors that further promote and amplify metabolic reprogramming in cancer cells. This review describes intrinsic and extrinsic mechanisms driving cancer metabolism in the tumor microenvironment and how such mechanisms may be targeted therapeutically. SIGNIFICANCE: Cancer cell metabolic reprogramming is a consequence of the converging signals originating from both intrinsic and extrinsic factors. Intrinsic signaling maintains the baseline metabolic state, whereas extrinsic signals fine-tune the metabolic processes based on the availability of metabolites and the requirements of the cells. Therefore, successful targeting of metabolic pathways will require a nuanced approach based on the cancer's genotype, tumor microenvironment composition, and tissue location.
代谢重编程使癌细胞能够生长、增殖和存活。这种重编程是由癌细胞中致癌改变和肿瘤微环境中作用于癌细胞的宿主细胞因子的共同作用驱动的。癌细胞内在机制激活信号转导成分,这些成分要么直接增强代谢酶的活性,要么上调转录因子,进而增加代谢调节剂的表达。外在信号机制涉及宿主来源的因子,这些因子进一步促进和放大癌细胞中的代谢重编程。这篇综述描述了内在和外在机制驱动肿瘤微环境中的癌症代谢,以及这些机制如何在治疗上被靶向。意义:癌细胞代谢重编程是源自内在和外在因素的汇聚信号的结果。内在信号维持着基本的代谢状态,而外在信号则根据代谢物的可利用性和细胞的需求来微调代谢过程。因此,成功靶向代谢途径将需要一种基于癌症基因型、肿瘤微环境组成和组织位置的细致方法。
Cancer Discov. 2021-5
Semin Cancer Biol. 2019-9-12
J Exp Clin Cancer Res. 2025-7-1
Cell Death Discov. 2025-8-19
Discov Oncol. 2025-8-13
Signal Transduct Target Ther. 2025-8-4
Nat Rev Cancer. 2025-7-24
Nat Commun. 2020-3-10
Cancer Discov. 2020-4
Nature. 2019-12-11